SCHEMBL1532425

SCHEMBL1532425

O=C(/C=C\c1ccccc1)OCCCc1ccccc1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 8/20 0.84
AKR1B1 P15121 8/20 0.84
MAOB P27338 1/20 0.69
ALOX5 P09917 3/20 0.68
LMNA P02545 3/20 0.67
APP P05067 2/20 0.60
CYP3A4 P08684 2/20 0.60
ALOX15 P16050 2/20 0.60
ALOX12 P18054 2/20 0.60
MAPK1 P28482 2/20 0.60
HSD17B10 Q99714 2/20 0.60
TTR P02766 2/20 0.60
KDM4E B2RXH2 1/20 0.60
MEN1 O00255 1/20 0.60
GMNN O75496 1/20 0.60
ALDH1A1 P00352 1/20 0.60
EGFR P00533 1/20 0.60
ESR1 P03372 1/20 0.60
ERBB2 P04626 1/20 0.60
LCK P06239 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1532424 1.00 AKR1B10 (0.84) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL3249348 1.00 AKR1B10 (0.84) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL20914961 0.91 AKR1B10 (1.00) AKR1B10AKR1B1MAOBALOX5LMNA
Phenethyl Cinnamate SCHEMBL4351248 0.90 AKR1B10 (1.00) AKR1B10AKR1B1MAOBALOX5LMNA
Phenethyl Cinnamate SCHEMBL43631 0.90 AKR1B10 (1.00) AKR1B10AKR1B1MAOBALOX5LMNA
Phenethyl Cinnamate SCHEMBL43632 0.90 AKR1B10 (1.00) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL25824433 0.89 AKR1B10 (1.00) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL8708780 0.89 HCAR2 (0.72) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL355843 0.89 HCAR2 (0.72) AKR1B10AKR1B1MAOBALOX5LMNA
SCHEMBL355844 0.89 HCAR2 (0.72) AKR1B10AKR1B1MAOBALOX5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP claimed
US-12121025-B2 Antimicrobial composition THE PROCTER & GAMBLE COMPANY (US) 2024-10-22 US disclosed
EP-4257663-A1 FOOD CONTACT SURFACE SANITIZING LIQUID The Procter & Gamble Company (US) 2023-10-11 EP disclosed
EP-3416729-B1 PRO-FRAGRANCE COMPOSITION AQDOT LTD (GB) 2023-09-20 EP disclosed
US-20220386600-A1 ANTIMICROBIAL COMPOSITION THE PROCTER & GAMBLE COMPANY 2022-12-08 US disclosed
EP-4098121-A1 ANTIMICROBIAL COMPOSITION The Procter & Gamble Company (US) 2022-12-07 EP disclosed
US-20220370535-A1 ANTIVIRAL ESSENTIAL OIL COMPOSITIONS ERDOGMUS, HÜSEYIN (TR) 2022-11-24 US disclosed
CN-110891615-B System and method for selecting and releasing fragrance 阿甘香气及精细化学有限公司 2022-08-05 CN disclosed
CN-108601958-B Pro-fragrance compositions 爱客多有限公司 2022-06-17 CN disclosed
US-10695277-B2 Pro-fragrance composition AQDOT LIMITED (GB) 2020-06-30 US disclosed
EP-3416729-A1 PRO-FRAGRANCE COMPOSITION Aqdot Limited (GB) 2018-12-26 EP disclosed
WO-2017141030-A1 PRO-FRAGRANCE COMPOSITION AQDOT LIMITED (GB) 2017-08-24 WO disclosed
CN-106999972-A System and method for discharging fragrance 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
CN-106999973-A System and method for discharging edible material 阿甘芳香和精细化工有限公司 2017-08-01 CN disclosed
EP-2292585-B1 Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound APTUIT WEST LAFAYETTE LLC (US) 2016-04-27 EP disclosed
US-8920559-B2 Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound APTUIT (WEST LAFAYETTE), LLC (US) 2014-12-30 US disclosed
US-20110257430-A1 NOVEL COCRYSTALLIZATION APTUIT (KANSAS CITY), LLC (US) 2011-10-20 US disclosed
US-20110251426-A1 SCREENING FOR SOLID FORMS BY ULTRASOUND CRYSTALLIZATION AND COCRYSTALLIZATION USING ULTRASOUND S.S.C.I., INC. (US) 2011-10-13 US disclosed
EP-2292585-A1 Screening for solid forms by ultrasound crystallization and cocrystallization using ultrasound APTUIT (KANSAS CITY), LLC (US) 2011-03-09 EP disclosed
US-20100248390-A1 COMPOSITIONS AND METHODS FOR IDENTIFYING LIGANDS OF ODORANT RECEPTORS DUKE UNIVERSITY (US) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220370535-A1 ANTIVIRAL ESSENTIAL OIL COMPOSITIONS CYP51A1, NR1H2, CYP2R1 AKR1B10 493/4885AKR1B1 412/4885MAOB 3189/4885
US-10695277-B2 Pro-fragrance composition COPS5, COPS8, CBR3 AKR1B10 2575/4885AKR1B1 4005/4885MAOB 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.